Abstract

F23 - Fulvestrant (FUL) 500 milligrams as endocrine therapy (ET) for hormone sensitive advanced breast cancer patients (pts). The Ful500 prospective observational trial

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Perspectives for the hormonal therapy of breast cancer
Sándor Eckhardt
Magyar Onkológia | VOL. 47
Sándor EckhardtSándor Eckhardt
16 Sep 2003
265P - Fulvestrant (FUL) 500 milligrams as endocrine therapy (ET) for hormone sensitive advanced breast cancer patients. The Ful500 prospective observational trial
L Moscetti ... E Ruggeri
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 27
L Moscetti, et. al.L Moscetti ... E Ruggeri
01 Oct 2016
The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials
Omar Najim ... Wiebren Tjalma
BBA - Reviews on Cancer | VOL. 1872
Omar Najim, et. al.Omar Najim ... Wiebren Tjalma
21 Oct 2019
Abstract P4-01-15: Theprevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS)
O Najim ... M Huizing
American Journal of Cancer | VOL. 79
O Najim, et. al.O Najim ... M Huizing
15 Feb 2019
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first-line and at relapse of chronic lymphocytic leukaemia
B Eichhorst ... C Buske
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
B Eichhorst, et. al.B Eichhorst ... C Buske
01 Jul 2024
Proofreading the way: immune checkpoint inhibitors in polymerase ε/polymerase δ (POLE/POLD1)-altered colorectal cancer
M Cecchini ... R Sundar
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
M Cecchini, et. al.M Cecchini ... R Sundar
01 Jul 2024
Table of Contents
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
View more papers